No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
EPRX Eupraxia Pharmaceuticals
- 2.990
- -0.010-0.33%
Close Dec 20 16:00 ET
106.51MMarket Cap-3.22P/E (TTM)
3.074High2.760Low7.78KVolume2.910Open3.000Pre Close22.50KTurnover0.03%Turnover RatioLossP/E (Static)35.62MShares4.08052wk High11.20P/B76.47MFloat Cap2.20052wk Low--Dividend TTM25.57MShs Float4.080Historical High--Div YieldTTM10.47%Amplitude2.200Historical Low2.892Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Eupraxia Pharma Shares Jump Following Data From Eosinophilic Esophagitis Trial
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
Eupraxia Pharmaceuticals Unveiled New Pharmacokinetic Data From Its Phase 2A Eosinophilic Esophagitis Program
Eupraxia Pharmaceuticals Brief: Says DiffuSphere Technology Demonstrates Targeted Drug Release While Minimizing Systemic Exposure for a Period of More Than Six Months
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting
Rodman & Renshaw Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $9
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List